PRICE T ROWE ASSOCIATES INC 13D and 13G filings for Legend Biotech Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 09:44 am Sale |
2024-12-31 | 13G | Legend Biotech Corporation LEGN |
PRICE T ROWE ASSOCIATES INC | 6,808,081 3.700% |
-4,357,503 (-39.03%) |
Filing |
| 2024-11-14 1:22 pm Purchase |
2024-09-30 | 13G | Legend Biotech Corporation LEGN |
PRICE T ROWE ASSOCIATES INC | 11,165,584 6.100% |
357,368 (+3.31%) |
Filing |
| 2024-02-14 10:03 am Purchase |
2023-12-31 | 13G | Legend Biotech Corporation LEGN |
PRICE T ROWE ASSOCIATES INC | 10,808,216 5.900% |
10,808,216 (New Position) |
Filing |